213 related articles for article (PubMed ID: 38612768)
1. Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy.
Olaoba OT; Adelusi TI; Yang M; Maidens T; Kimchi ET; Staveley-O'Carroll KF; Li G
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791887
[TBL] [Abstract][Full Text] [Related]
2. Protein Arginine Methyltransferases in Pancreatic Ductal Adenocarcinoma: New Molecular Targets for Therapy.
Bhandari K; Ding WQ
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612768
[TBL] [Abstract][Full Text] [Related]
3. Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance.
Gao Y; Feng C; Ma J; Yan Q
Biochem Pharmacol; 2024 Mar; 221():116048. PubMed ID: 38346542
[TBL] [Abstract][Full Text] [Related]
4. Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance.
Zhu Y; Xia T; Chen DQ; Xiong X; Shi L; Zuo Y; Xiao H; Liu L
Drug Resist Updat; 2024 Jan; 72():101016. PubMed ID: 37980859
[TBL] [Abstract][Full Text] [Related]
5. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expression.
Kim SS; Xu S; Cui J; Poddar S; Le TM; Hayrapetyan H; Li L; Wu N; Moore AM; Zhou L; Yu AC; Dann AM; Elliott IA; Abt ER; Kim W; Dawson DW; Radu CG; Donahue TR
Theranostics; 2020; 10(2):829-840. PubMed ID: 31903153
[TBL] [Abstract][Full Text] [Related]
7. PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma.
Giuliani V; Miller MA; Liu CY; Hartono SR; Class CA; Bristow CA; Suzuki E; Sanz LA; Gao G; Gay JP; Feng N; Rose JL; Tomihara H; Daniele JR; Peoples MD; Bardenhagen JP; Geck Do MK; Chang QE; Vangamudi B; Vellano C; Ying H; Deem AK; Do KA; Genovese G; Marszalek JR; Kovacs JJ; Kim M; Fleming JB; Guccione E; Viale A; Maitra A; Emilia Di Francesco M; Yap TA; Jones P; Draetta G; Carugo A; Chedin F; Heffernan TP
Nat Commun; 2021 Jul; 12(1):4626. PubMed ID: 34330913
[TBL] [Abstract][Full Text] [Related]
8. Protein Arginine Methylation Patterns in Plasma Small Extracellular Vesicles Are Altered in Patients with Early-Stage Pancreatic Ductal Adenocarcinoma.
Bhandari K; Kong JS; Morris K; Xu C; Ding WQ
Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339405
[TBL] [Abstract][Full Text] [Related]
9. Cancer statistics, 2024.
Siegel RL; Giaquinto AN; Jemal A
CA Cancer J Clin; 2024; 74(1):12-49. PubMed ID: 38230766
[TBL] [Abstract][Full Text] [Related]
10. Tumor-suppressive functions of protein lysine methyltransferases.
Aziz N; Hong YH; Kim HG; Kim JH; Cho JY
Exp Mol Med; 2023 Dec; 55(12):2475-2497. PubMed ID: 38036730
[TBL] [Abstract][Full Text] [Related]
11. Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion.
Liu Y; Liu H; Ye M; Jiang M; Chen X; Song G; Ji H; Wang ZW; Zhu X
Cell Death Dis; 2023 Sep; 14(9):624. PubMed ID: 37737256
[TBL] [Abstract][Full Text] [Related]
12. Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors.
El-Khoueiry AB; Clarke J; Neff T; Crossman T; Ratia N; Rathi C; Noto P; Tarkar A; Garrido-Laguna I; Calvo E; Rodón J; Tran B; O'Dwyer PJ; Cuker A; Abdul Razak AR
Br J Cancer; 2023 Aug; 129(2):309-317. PubMed ID: 37237172
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in targeted therapy for pancreatic adenocarcinoma.
Fang YT; Yang WW; Niu YR; Sun YK
World J Gastrointest Oncol; 2023 Apr; 15(4):571-595. PubMed ID: 37123059
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
